Sika Interplant Systems Board of Directors
Get the latest insights into the leadership at Sika Interplant Systems. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Rajeev Sikka | Executive Chairman |
| Mr. Kunal Sikka | Managing Director & CEO |
| Mrs. Anuradha Sikka | Non Executive Director |
| Mr. Sushil Khanna | Independent Director |
| Mr. G V S Bhaskar | Independent Director |
| Mr. P Jayapal | Independent Director |
Sika Interplant Systems Share price
SIKA
1131.9
14.10 (-1.23%)Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
1158.00
Today's Low
1130.00
52 Week Low
399.96
52 Week High
1624.95
The current prices are delayed, login to your account for live prices
LoginSika Interplant Systems FAQs
The board at Sika Interplant Systems consists of experienced professionals, including Mr. Rajeev Sikka , Mr. Kunal Sikka , and others, overseeing the company’s strategic and corporate governance.
Directors at Sika Interplant Systems are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Rajeev Sikka is the current chairman at Sika Interplant Systems.
Executive directors at Sika Interplant Systems are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sika Interplant Systems adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sika Interplant Systems, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.